Revolution Medicines (RVMD) stock news
Every headline mentioning Revolution Medicines from Investing.com, MarketWatch and Nasdaq over the last 30 days, each scored for sentiment and importance. Updated automatically through the trading day.
Headlines2last 7 days · 3 in 30 days
Sentiment, 30 days
3 positive0 neutral0 negative
Latest headlineFri 6 Nov, 17:14 UTCHealthcare
Latest RVMD headlines
Friday, 6 November 2026
Thursday, 5 November 2026
This pancreatic cancer treatment is on track for ‘one of the best drug launches of all time’
Revolution Medicines’ brand-new treatment brought in far higher sales than expected in its first few weeks on the market.
Saturday, 17 October 2026
William Blair Initiates Coverage of Revolution Medicines at Outperform
Fintel reports that on October 16, 2026, William Blair initiated coverage of Revolution Medicines (NASDAQGS:RVMD) (BIT:1RVMD) with a Outperform recommendation.Revolution Medicines, Inc., based in the United States, operates within the…